Moorella group Details: NCBI 42857, gram-negative or unknown [norank]

| Clostridium thermoautotrophicum group| cluster VII| Moorella group

  1. Biotechnological applications: Many species within the Moorella group possess unique metabolic capabilities that make them valuable in various biotechnological processes. For example, they are involved in the conversion of carbon monoxide (CO) and hydrogen (H2) to acetate through the Wood-Ljungdahl pathway, a process known as syngas fermentation. This metabolic feature has applications in biofuel production, bioremediation, and the synthesis of valuable chemicals.

  2. Gut microbiota: Some species within the Moorella group have been identified in the gut microbiota of humans and other animals. While their specific roles in the gut microbiome and their interactions with the host are not well-understood, they may contribute to the fermentation of complex carbohydrates and the production of short-chain fatty acids (SCFAs) in the colon. SCFAs play important roles in gut health, energy metabolism, and immune regulation.

  3. Hydrogen production: Certain members of the Moorella group are capable of producing hydrogen gas (H2) as a metabolic byproduct during fermentation. Hydrogen production by these bacteria has potential applications in biohydrogen production, which is a promising renewable energy source.

  4. Thermophilic environments: The Moorella group is often found in thermophilic environments such as hot springs, geothermal areas, and deep-sea hydrothermal vents. While these environments are not directly relevant to human health, studying the metabolic pathways and physiological adaptations of Moorella species in extreme conditions provides insights into their ecological roles and biotechnological potential.

  5. Methanogenesis: Some species within the Moorella group are involved in methanogenesis, the biological production of methane gas (CH4). Methanogenic archaea often coexist with bacteria such as Moorella in anaerobic environments and form syntrophic relationships. Methane production by these microbes has implications for carbon cycling in natural ecosystems and anaerobic digestion processes.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Moorella group

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.02 4 530 0 479 141.2 50 172.5 0 290 0 %ile 100 %ile
biomesight 75.4 0 220 30 470 0 1893 354.7 140 784.8 0 520 8 %ile 90.7 %ile
thorne 100 2 50 0 43 17.6 10 12.8 8 38 0 %ile 100 %ile
thryve 3.97 6 370 0 152 34.8 20 59.8 4 40 0 %ile 100 %ile

External Reference Ranges for Moorella group

Moorella group (NCBI 42857) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Moorella group
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 67.423 %   0.035 %  0.078 % 1991.0 2953
BiomeSightRdp 62.5 %   0.048 %  0.071 % 20.0 32
CerbaLab 66.667 %   0.002 %  0.001 % 2.0 3
custom 3.279 %   0.026 %  0.036 % 2.0 61
es-xenogene 17.241 %   0.007 %  0.003 % 5.0 29
Medivere 14.286 %   0.002 %  % 1.0 7
Thorne 59.14 %   0.001 %  0.001 % 55.0 93
Thryve 3.971 %   0.005 %  0.011 % 55.0 1385

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.